Skip to main content Accessibility help
×
Home

Frequency, Risk Factors, and Outcomes of Vancomycin-Resistant Enterococcus Colonization and Infection in Patients with Newly Diagnosed Acute Leukemia: Different Patterns in Patients with Acute Myelogenous and Acute Lymphoblastic Leukemia

  • Clyde D. Ford (a1), Bert K. Lopansri (a2), Souha Haydoura (a2), Greg Snow (a3), Kristin K. Dascomb (a2), Julie Asch (a1), Finn Bo Petersen (a1) and John P. Burke (a2)...

Abstract

OBJECTIVE

To determine the frequency, risk factors, and outcomes for vancomycin-resistant Enterococcus (VRE) colonization and infection in patients with newly diagnosed acute leukemia.

DESIGN

Retrospective clinical study with VRE molecular strain typing.

SETTING

A regional referral center for acute leukemia.

PATIENTS

Two hundred fourteen consecutive patients with newly diagnosed acute leukemia between 2006 and 2012.

METHODS

All patients had a culture of first stool and weekly surveillance for VRE. Clinical data were abstracted from the Intermountain Healthcare electronic data warehouse. VRE molecular typing was performed utilizing the semi-automated DiversiLab System.

RESULTS

The rate of VRE colonization was directly proportional to length of stay and was higher in patients with acute lymphoblastic leukemia. Risk factors associated with colonization include administration of corticosteroids (P=0.004) and carbapenems (P=0.009). Neither a colonized prior room occupant nor an increased unit colonization pressure affected colonization risk. Colonized patients with acute myelogenous leukemia had an increased risk of VRE bloodstream infection (BSI, P=0.002). Other risk factors for VRE BSI include severe neutropenia (P=0.04) and diarrhea (P=0.008). Fifty-eight percent of BSI isolates were identical or related by molecular typing. Eighty-nine percent of bloodstream isolates were identical or related to stool isolates identified by surveillance cultures. VRE BSI was associated with increased costs (P=0.0003) and possibly mortality.

CONCLUSIONS

VRE colonization has important consequences for patients with acute myelogenous leukemia undergoing induction therapy. For febrile neutropenic patients with acute myelogenous leukemia, use of empirical antibiotic regimens that avoid carbapenems and include VRE coverage may be helpful in decreasing the risks associated with VRE BSI.

Infect Control Hosp Epidemiol 2015;36(1): 47–53

Copyright

Corresponding author

Address correspondence to Clyde D. Ford, MD, Intermountain Acute Leukemia and Blood and Marrow Transplant Program, LDS Hospital, Eighth Avenue and C Street, Salt Lake City, UT 84143 (clyde.ford@imail.org).

References

Hide All
1.Butler, AM, Olsen, MA, Merz, LR, et al. The attributable costs of enterococcal bloodstream infections in a non-surgical hospital cohort. Infect Control Hosp Epidemiol 2010;31:2835.
2.Vydra, J, Shanley, RM, George, I, et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:764770.
3.Worth, LJ, Thursky, KA, Seymour, JF, Slavin, MA. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007;79:226233.
4.Bossaer, JB, Hall, PD, Garrett-Mayer, E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2011;19:231237.
5.Colderwood, MS, Mauer, A, Tolentino, J, et al. Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program. Infect Control Hosp Epidemiol 2008;29:10191025.
6.Almyroudis, NG, Lesse, AJ, Hahn, T, et al. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol 2011;32:490496.
7.Bonten, MJM, Slaughter, S, Ambergen, AW, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci. Arch Intern Med 1998;158:11271132.
8.Livornese, LL, Dias, S, Samel, C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Annals Intern Med 1992;117:112116.
9.Batistao, DWdF, Gontijo-Filho, PPG, Conceicao, N, de Oliveira, AG, Ribas, RM. Risk factors for vancomycin-resistant enterococci colonization in critically ill patients. Mern Inst Oswaldo Cruz, Rio de Janeiro 2012;107:5763.
10.Yoon, KY, Lee, SE, Lee, J, Kin, HJ, et al. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother 2011;66:18311838.
11.McKinnell, JA, Kunz, DF, Chamot, E, et al. Association between vancomycin-resistant enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol 2012;33:718724.
12.Fridkin, SK, Edwards, JR, Courval, JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001;135:175183.
13.Ghanem, G, Hachem, R, Jiang, Y, Chemaly, RF, Raad, I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol 2007;28:10541059.
14.Donskey, CJ, Chowdhry, TK, Hecker, MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:19251932.
15.Taur, Y, Xavier, JB, Lipuma, L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:905914.
16.Olivier, CN, Blake, RK, Steed, LL, Salgado, CD. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 2008;29:404409.
17.Lodise, TP, McKinnon, PS, Tam, VH, Rybak, MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 2002;34:922929.
18.DiazGranados, CA, Jernigan, JA.Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005;191:588595.
19.Zirakzadeh, A, Gastineau, DA, Mandrekar, JN, Burke, JP, Johnston, PB, Patel, R. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2008;41:385392.
20.Dress, M, Snydman, DR, Schmid, CH, et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008;46:678685.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed